Barclays analyst Benjamin Budish raised the firm’s price target on Carlyle (CG) to $49 from $43 and keeps an Overweight rating on the shares. The company’s Q1 earnings came in ahead of the Street and management projected a confident tone in the face of ongoing market volatility, the analyst tells investors in a research note.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- Carlyle Group Reports Strong Q1 2025 Financial Results
- Carlyle Group’s Earnings Call: Record Growth Amid Challenges
- BofA says crowded PE fundraising backdrop to have ‘pronounced impact’ on Carlyle
- Carlyle reports Q1 adjusted EPS $1.14, consensus 95c
- Carlyle, SK receive approvals to complete Bluebird Bio acquisition